Invention Application
- Patent Title: NOVEL TRICYCLIC COMPOUNDS
- Patent Title (中): 新型三聚体化合物
-
Application No.: US14610119Application Date: 2015-01-30
-
Publication No.: US20150210708A1Publication Date: 2015-07-30
- Inventor: Neil Wishart , Maria A. Argiriadi , David J. Calderwood , Anna M. Ericsson , Bryan A. Fiamengo , Kristine E. Frank , Michael M. Friedman , Dawn M. George , Eric R. Goedken , Nathan S. Josephsohn , Biqin C. Li , Michael J. Morytko , Kent D. Stewart , Jeffrey W. Voss , Grier A. Wallace , Lu Wang , Kevin R. Woller
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Main IPC: C07D487/14
- IPC: C07D487/14

Abstract:
The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Public/Granted literature
- US09365579B2 Tricyclic compounds Public/Granted day:2016-06-14
Information query